Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
about
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.New Pharmacotherapies in Chronic Lymphocytic Leukemia.Magic pills: new oral drugs to treat chronic lymphocytic leukemia.Current Treatment of Chronic Lymphocytic Leukemia.Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial.Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide.Chronic lymphocytic leukaemia
P2860
Q33436535-C76A6EA1-2457-496E-9F3E-9C5F4EF9F2ECQ37605306-149C189C-D665-4CB9-AA15-D24421644635Q38943877-1C91CC98-C472-4C8A-9B8B-20E6C38A43CEQ39129372-C2B24E36-3769-40BE-B3BD-DCAC9AA0161AQ40438184-F85A9848-EF9A-4338-990B-66B62E250969Q50864223-07EAD583-45F8-4DAE-8EA4-938E2E36BECBQ56270980-CE5957F4-9A41-429C-B29D-4A122B75D019
P2860
Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ofatumumab and Lenalidomide fo ...... ses and Immune Characteristics
@en
Ofatumumab and Lenalidomide fo ...... es and Immune Characteristics.
@nl
type
label
Ofatumumab and Lenalidomide fo ...... ses and Immune Characteristics
@en
Ofatumumab and Lenalidomide fo ...... es and Immune Characteristics.
@nl
prefLabel
Ofatumumab and Lenalidomide fo ...... ses and Immune Characteristics
@en
Ofatumumab and Lenalidomide fo ...... es and Immune Characteristics.
@nl
P2093
P2860
P50
P1476
Ofatumumab and Lenalidomide fo ...... ses and Immune Characteristics
@en
P2093
Candida Vitale
Elisa Ten Hacken
Hila Shaim
James M Reuben
Jan A Burger
Katayoun Rezvani
Katrien Van Roosbroeck
Lorenzo Falchi
Xuemei Wang
P2860
P304
P356
10.1158/1078-0432.CCR-15-2476
P407
P577
2016-01-05T00:00:00Z